Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;5(2):136-140.
doi: 10.1007/s40135-017-0131-6. Epub 2017 Mar 31.

OCT Angiography: An Upcoming Non-invasive Tool for Diagnosis of Age-related Macular Degeneration

OCT Angiography: An Upcoming Non-invasive Tool for Diagnosis of Age-related Macular Degeneration

Luiz Roisman et al. Curr Ophthalmol Rep. 2017 Jun.

Abstract

Purpose: To review the most recent findings, characteristics, faults and future perspectives of optical coherence tomography angiography (OCTA) in age-related macular degeneration (AMD).

Recent findings: In dry AMD, OCTA is useful on the evaluation of choriocapillaris perfusion and detection of naïve quiescent non-exudative choroidal neovascularization (CNV). In wet AMD, OCTA can provide detailed anatomic and morphologic information of CNVs, which may help to understand why and how they develop and become active. In other hand, the many artifacts present in OCTA images may lead to misinterpretation and misdiagnosis.

Summary: OCTA is a still developing technology that is able to provide a large amount of anatomic, functional and morphologic information in macular diseases and, particularly, AMD. As the technology evolves, the need of dye-based modalities tends to decrease.

Keywords: age-related macular degeneration (AMD); optical coherence tomography angiography (OCTA).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Raquel Goldhardt and Luiz Roisman declare no conflict of interest.

Figures

Figure 1
Figure 1
Spectral-domain (SD) optical coherence tomography angiography of a type 1 choroidal neovascularization from one eye of patient with exudative age-related macular degeneration. (A) 3×3 mm en face flow angiogram extracted from the slab shown on C revealing the neovascular network of a type 1 choroidal neovascularization (CNV); (B) 6×6 mm en face flow angiogram extracted from the slab shown on D. Differently from the 3×3 mm angiogram shown on A, the CNV is almost indistinguishable from the surrounding choriocapillaris due to lower resolution of the 6×6 angiogram. (C and D) B-scan from which the 3×3 and 6×6 mm angiogram on A and C, respectively, were extracted demonstrating the boundaries of the slab; top boundary under the retinal pigment epithelium and bottom boundary under the Bruch’s membrane.
Figure 2
Figure 2
En face flow angiograms from diferente morphologic patterns of choroidal neovascularization (CNV). (A) Medusa shape, showing vessels radiating from the center to all directions; (B) seafan shape, presenting with vessels branching to one side of the main trunk; (C) glomerular shape, defined as globular structures with intertwined vessels; and (D) “dead tree” shape, composed by a main pruned vascular trunk.

References

    1. Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115:116–26. - PubMed
    1. NM B. Age-related macular degeneration is the leading cause of blindness. JAMA ophthalmology. 2004;291:1900–1. - PubMed
    1. Cruess AF, Zlateva G, Pleil AM, Wirostko B. Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta ophthalmologica. 2009;87:118–32. - PubMed
    1. Su Z, Ye P, Teng Y, Zhang L, Shu X. Adverse reaction in patients with drug allergy history after simultaneous intravenous fundus fluorescein angiography and indocyanine green angiography. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics. 2012;28:410–3. - PubMed
    1. Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, et al. Fluorescein angiography complication survey. Ophthalmology. 1986;93:611–7. - PubMed

LinkOut - more resources